UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2023
Commission File Number 001-41749
PIXIE DUST TECHNOLOGIES, INC.
(Translation of registrant’s name into English)
Pixie Dust Technologies, Inc.
2-20-5 Kanda Misaki-cho, Chiyoda-ku
Tokyo, 101-0061, Japan
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F: ☒ Form 20-F ☐ Form 40-F
INFORMATION
CONTAINED IN THIS FORM 6-K REPORT
Issuance of Press Release
On October 27, 2023, Pixie Dust Technologies,
Inc. (the “Company”) issued a press release to announce a joint research agreement with Tohoku University School of Medicine.
The press release furnished in this report as Exhibit 99.1 shall not
be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities
Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
Date: October 27, 2023 |
Pixie Dust Technologies, Inc. |
|
|
|
|
By: |
/s/ Yoichi Ochiai |
|
|
Name: |
Yoichi Ochiai |
|
|
Title: |
Chief Executive Officer |
2
Exhibit 99.1
Pixie Dust Technologies, Inc. Announces Collaborative
Research Agreement with Tohoku University School of Medicine
NEW YORK, NY and TOKYO, Japan, Oct. 27, 2023 - Pixie Dust Technologies,
Inc. (Nasdaq: PXDT) (the “Company”), a Japanese technology company focused on commercializing innovative products and materials
utilizing proprietary wave technology, announced a joint research agreement with Tohoku University School of Medicine (the “University”)
for the purpose of developing and commercializing certain non-pharmaceutical skin disease treatments using wave control technology.
Since 2020, the Company has had an ongoing partnership with the University,
combining the Company’s wave control technology with University resources and knowledge. While the previous focus of this partnership
was on a wide range of societal healthcare issues, today’s agreement has the specific focus of pioneering an innovative, non-pharmaceutical
approach to skin disease treatment using ultrasonic technology.
About Tohoku University
Name: National University Corporation Tohoku University
President: Hideo Ohno
Location: 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi
Prefecture
Established: June 1907
URL: https://www.tohoku.ac.jp/en/
Since its establishment in 1907, Tohoku University
has been leading the way in the pursuit of truth, guided by its principles of ‘Research First,’ ‘Open Doors,’ and ‘Practice Oriented Research
and Education.’ The University has produced many eminent leaders and achieved globally acclaimed research outcomes that have expanded
the horizons of human knowledge and spearheaded transformation and innovation for future societies. In July 2020, the University updated
the ‘Vision 2030,’ first laid out in 2018, and formulated the ‘Connected University Strategy.’ The University strongly promoted the digitalization
of education, research, and co-creation with society, showcasing the roadmap towards a borderless, diverse, and truly inclusive university
through the integrated use of cyberspace and physical spaces. In 2021, the University declared the ‘Green Goals Initiative,’ taking a
new step toward creating a prosperous future. Moving forward, the University will continue to evolve alongside society as a comprehensive
research university, addressing humanity’s shared challenges such as the Sustainable Development Goals (SDGs), the Great Reset in the
post- pandemic era, and achieving carbon neutrality, all grounded on solid research.
About Pixie Dust Technologies, Inc.
Pixie Dust Technologies, Inc. is a Japanese technology company focused
on commercializing innovative products and materials utilizing proprietary wave technology. The Company is currently focusing on two areas
of product development: (1) “Personal Care & Diversity”, where wave control technology is applied to mechanobiology and
intervention/assistance in vision, hearing, and touch, and (2) “Workspace & Digital Transformation,” where metamaterials
(technology that creates properties through structure rather than material) and solutions to commercial design problems, such as in offices
or construction sites, are applied.
Contact:
Pixie Dust Technologies, Inc. PR Department
Inquiry: https://pixiedusttech.com/contact/
Tohoku University Graduate School of Medicine
/ Medical Department Public Relations Office
Tohoku University Hospital Public Relations Office
Contact:
TEL: +81-22-717-8032
E-mail: press@pr.med.tohoku.ac.jp
Pixie Dust Technologies (NASDAQ:PXDT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pixie Dust Technologies (NASDAQ:PXDT)
Historical Stock Chart
From Sep 2023 to Sep 2024